Members Login Join NHIVNA
Patrons Executive Committee Subcommittees & Working Groups Objectives and Powers Annual Report & Accounts Membership
You are here: > News

Featured NHIVNA news

HIV Nursing 2017
by NHIVNA Admin, 2017-06-17 10:55

National Standards of Peer Support in HIV launched
by NHIVNA Admin, 2017-06-15 10:05

Advanced Nursing practice in HIV care: Guidelines for nurses, doctors, service providers and commissioners
by NHIVNA Admin, 2016-08-18 09:20

Other latest news

New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate
Gus Cairns, 2017-09-12 12:10

A new US model of the cost-effectiveness of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM), prepared by researchers at Emory University in Atlanta, finds that taking even one year of PrEP is more cost-effective than measures like kidney dialysis, if it is used by people belonging to populations where HIV prevalence is at least 10%.

However, for PrEP to actually save money, relative to the lifetime cost of treating the HIV infections that would otherwise happen, either average adherence to PrEP needs to be high enough for it to be more than 92% effective, or the population prevalence of HIV has to be over 20%, or there has to be a reduction in the price of PrEP of at least 80%.

The model finds that the two most significant factors in whether PrEP saves money or not are population HIV prevalence, and adherence. (PrEP saves money when background HIV prevalence is high because it prevents more of the infections that would otherwise have occurred.)

As a result, the authors say, PrEP could be cost-effective with modest price reductions in states like Georgia but would need to be discounted substantially, or only taken by a targeted few, to be cost-effective in low-prevalence states like Montana.

© Copyright National HIV Nurses Association (NHIVNA) 2017
     Registered Charity Number 1099074